TargetMol

13,21-Dihydroeurycomanone

Product Code:
 
TAR-TN7103
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TN7103-1mg1mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7103-5mg5mg£271.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7103-1mL1 mL * 10 mM (in DMSO)£287.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7103-10mg10mg£366.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN7103-25mg25mg£571.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
13,21-Dihydroeurycomanone is a natural product isolated from the root of Eurycoma longifolia with antiparasitic activity such as Plasmodium falciparum and Toxoplasma gondii.
CAS:
129587-06-0
Formula:
C20H26O9
Molecular Weight:
410.42
Pathway:
Microbiology/Virology
Purity:
0.9801
SMILES:
CC([C@](C[C@@](O1)2[H])3[H])=CC([C@@H](O)[C@]3(C)[C@]4([H])[C@]2(CO[C@@]4(O)[C@H](O)[C@@H]5C)[C@@]5(O)[C@@H](O)C1=O)=O
Target:
Anti-infection; Parasite

References

Nowroji Kavitha, et al. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack. BMC Complement Altern Med. 2012 Jul 10;12:91. Walther H Wernsdorfer, et al. Activity of Eurycoma longifolia root extract against Plasmodium falciparum in vitro. Wien Klin Wochenschr. 2009 Oct;121 Suppl 3:23-6.